文献速递头颈技术与安全PETCT

乳酸脱氢酶A与分化型甲状腺癌FDG代谢升高、放射性碘非亲和及不良预后相关

Lactate Dehydrogenase A is Associated with Elevated FDG Metabolism, Radioiodine Non-avidity, and Poor Prognosis in Differentiated Thyroid Cancer.
PubMed 文献 · Acad Radiol · 2024-06-12

该研究纳入69例接受18F-FDG PET/CT及甲状腺全切或转移灶切除的分化型甲状腺癌患者,用免疫组化测LDHA、Glut及Ki67表达,分析其与PET代谢参数及放射性碘亲和性的关系。结果显示LDHA表达与Glut3及SUVmax相关,放射性碘非亲和组LDHA表达及病灶SUVmax更高,TLG为无进展时间的独立预后因素。

要点

  • 放射性碘非亲和组病灶SUVmax中位数8.38,高于亲和组的3.06(P=0.038)。
  • LDHA表达与Glut3表达(r=0.395,P=0.003)及SUVmax(r=0.408,P=0.002)相关。
  • TLG为无进展时间的独立预后因素(HR 4.773,P=0.047)。

核心结论

  • LDHA表达升高与葡萄糖代谢增高、放射性碘亲和性降低及疾病进展加快相关,18F-FDG PET/CT可作为「在体病理」预测DTC预后。

研究设计与样本

  • 研究纳入69例接受18F-FDG PET/CT后行甲状腺全切或转移灶切除的DTC患者,用免疫组化测肿瘤组织LDHA、Glut及Ki67蛋白表达,测PET的SUVmax、MTV、TLG,用放射性碘全身扫描判定病灶碘亲和性。

关键影像表现/征象

  • 放射性碘非亲和组病灶SUVmax中位数8.38,高于亲和组的3.06(P=0.038)。
  • 放射性碘非亲和组LDHA表达中位数285,高于亲和组的200(P=0.036)。
  • LDHA表达与Glut3表达相关(r=0.395,P=0.003),与SUVmax相关(r=0.408,P=0.002)。

诊断标准与关键数值

  • SUVmax升高(P=0.004)、MTV升高(P=0.014)、TLG升高(P=0.001)及LDHA表达升高(P=0.048)者无进展时间更短。
  • Cox回归显示TLG为无进展时间的独立预后因素(HR 4.773,P=0.047)。

临床应用与阅片要点

  • 作者认为18F-FDG PET/CT作为「在体病理」是DTC预后的良好预测手段。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The role of lactate dehydrogenase A (LDHA) expression in differentiated thyroid cancer (DTC), especially in radioiodine-refractory DTC, remains unclear. The aim of this study was to analyse the relationships and the prognostic value of LDHA, glycolysis, and radioactive iodine (RAI) avidity in DTC.

METHODS: DTC patients who underwent 18F-FDG PET/CT and subsequent total thyroidectomy or metastasectomy were enroled. The expression levels of LDHA, glucose transporters (Glut) and Ki67 proteins in tumour tissue were measured using immunohistochemistry. The maximum standardised uptake value (SUVmax), metabolic tumour volume (MTV) and total lesion glycolysis (TLG) of 18F-FDG PET/CT were measured. A radioiodine whole body scan was used to determine lesion radioiodine avidity.

RESULTS: 69 patients with DTC were enroled in this study, including 37 women (53.6%) and 32 men (46.4%), with a median age of 52 years (11 to 77 years). Regarding the pathological category, papillary thyroid cancer was documented in 50 patients (72.5%), while follicular and poorly differentiated thyroid cancer were found in 12 patients (17.4%) and seven patients (10.1%), respectively. Distant metastases were observed in 27 (39.1%) patients; 34 (49.3%) were classified as stage I, 16 (23.2%) as stage II, and 3 (4.3%) and 16 (23.2%) patients in stages III and IV, respectively. LDHA expression levels were correlated with Glut3 expression levels (r = 0.395, P = 0.003) and SUVmax (r = 0.408, P = 0.002). The median LDHA expression and lesion SUVmax of the RAI avidity group were lower than those of the non-RAI avidity group (200 vs. 285, P = 0.036; 3.06 vs. 8.38, P = 0.038, respectively). Elevated SUVmax (P = 0.004), MTV (P = 0.014), TLG (P = 0.001) and LDHA expression (P = 0.048) led to shorter time to progression (TTP); Cox regression analysis revealed that TLG (HR: 4.773, P = 0.047) was an independent prognostic factor of TTP.

CONCLUSION: Elevated LDHA is correlated with increased glucose metabolism, decreased radioiodine avidity, and accelerated disease progression. Moreover, 18F-FDG PET/CT acting as "in vivo pathology" is an excellent predictor of DTC prognosis.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Tian T, Dai H, Zhang M, et al. Lactate Dehydrogenase A is Associated with Elevated FDG Metabolism, Radioiodine Non-avidity, and Poor Prognosis in Differentiated Thyroid Cancer. Acad Radiol. 2024. PMID: 38866688. doi:10.1016/j.acra.2024.04.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。